Effect of Single Annual Infusion of Zoledronic Acid On Bone Turnover Markers Versus Daily Oral Risedronate in Patients With Glucocorticoid-induced Osteoporosis

Sambrook, P.;Devogelaer, Jean-Pierre;Reid, D.;Reginster, Jacques;Mesenbrink, P.;et.al.
(2009) 9th European Congress on Clinical an dEconomic Aspects of Osteoporosis and Osteoarthritis — Location: Athens (Greece) (19.March.2009)

Files

No attached file found for this publication.

Details

Authors
  • Sambrook, P.
    Author
  • Devogelaer, Jean-PierreUCLouvain
    Author
  • Reid, D.
    Author
  • Reginster, JacquesUCLouvain
    Author
  • Roux, ChristianUCLouvain
    Author
  • Mesenbrink, P.
    Author
Show more
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Sambrook, P., Devogelaer, J.-P., Reid, D., Reginster, J., Saag, K., Roux, C., Papanastasiou, P., Maylandt, K., Fashola, T., & Mesenbrink, P. (2009). Effect of Single Annual Infusion of Zoledronic Acid On Bone Turnover Markers Versus Daily Oral Risedronate in Patients With Glucocorticoid-induced Osteoporosis. Osteoporosis International : with other metabolic bone diseases, 20, 128-129. https://hdl.handle.net/2078.5/147116 (Original work published 2009)